Research
Researchers found that pairing a next-generation immunotherapy with standard hormone therapy before surgery may help overcome a long-standing barrier in early-stage prostate cancer treatment.
Latest stories
Biotherapeutics
February 25, 2026
Neurosciences
February 23, 2026
Cancer
February 19, 2026
Cancer
February 16, 2026
AI and Digital Health
February 16, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community